Health Catalyst (HCAT) Stock Analysis & Price (Updated Oct 16, 2026, 4:00 PM ET)
Updated Oct 16, 2026, 4:00 PM ET
- Closed at $1.73, -4.17% vs the prior close of $1.80.
- Volume 176.67K shares, 0.3x its 50-day average (light).
- No new SEC filings since the prior session.
- No new insider buys or sales reported since the prior session.
HCAT slides 4.2% to $1.73. Closed at $1.73, -4.17% vs the prior close of $1.80. Day range $1.72–$1.84, opened at $1.80.
HCAT daily analysis — what happened
A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.
Oct 16, 2026 — HCAT slides 4.2% to $1.73
- Closed at $1.73, -4.17% vs the prior close of $1.80. Day range $1.72–$1.84, opened at $1.80.
- Volume was 176.67K shares, 0.3x its 50-day average of 652.49K — lighter than usual.
- Price is +0.1% vs its 50-day average ($1.72) and -1.4% vs its 200-day average ($1.75).
- 52-week range $0.95–$3.62; today's close sits at 29% of that range, 52.3% below the 52-week high.
Oct 15, 2026 — HCAT jumps 3.4% to $1.80
- Closed at $1.80, +3.45% vs the prior close of $1.74. Day range $1.74–$1.81, opened at $1.74.
- Volume was 306.80K shares, 0.5x its 50-day average of 664.56K — lighter than usual.
- Price is +3.8% vs its 50-day average ($1.73) and +2.7% vs its 200-day average ($1.75).
- 52-week range $0.95–$3.62; today's close sits at 32% of that range, 50.2% below the 52-week high.
Oct 14, 2026 — HCAT ends flat (+0.0%) to $1.74, 3 down days in a row
- Closed at $1.74, +0.00% vs the prior close of $1.74. Day range $1.71–$1.75, opened at $1.71.
- Volume was 458.30K shares, 0.7x its 50-day average of 664.82K.
- Price is -0.3% vs its 50-day average ($1.75) and -0.9% vs its 200-day average ($1.76).
- 52-week range $0.95–$3.62; today's close sits at 30% of that range, 51.9% below the 52-week high.
- That makes 3 straight losses.
Oct 13, 2026 — HCAT dips 0.6% to $1.74 on 1.9x normal volume
- Closed at $1.74, -0.57% vs the prior close of $1.75. Day range $1.65–$1.79, opened at $1.75.
- Volume was 1.27M shares, 1.9x its 50-day average of 654.28K — unusually heavy trading.
- Price is -1.0% vs its 50-day average ($1.76) and -1.1% vs its 200-day average ($1.76).
- 52-week range $0.95–$3.62; today's close sits at 30% of that range, 51.9% below the 52-week high.
Oct 12, 2026 — HCAT dips 1.1% to $1.75
- Closed at $1.75, -1.13% vs the prior close of $1.77. Day range $1.71–$1.81, opened at $1.79.
- Volume was 345.30K shares, 0.5x its 50-day average of 655.35K — lighter than usual.
- Price is -0.9% vs its 50-day average ($1.77) and -0.7% vs its 200-day average ($1.76).
- 52-week range $0.95–$3.62; today's close sits at 30% of that range, 51.6% below the 52-week high.
Oct 9, 2026 — HCAT rises 1.1% to $1.77
- Closed at $1.77, +1.14% vs the prior close of $1.75. Day range $1.70–$1.79, opened at $1.76.
- Volume was 1.02M shares, 1.6x its 50-day average of 644.99K.
- Price is -0.2% vs its 50-day average ($1.77) and +0.2% vs its 200-day average ($1.77).
- 52-week range $0.95–$3.62; today's close sits at 31% of that range, 51.0% below the 52-week high.
Oct 8, 2026 — HCAT dips 0.6% to $1.75
- Closed at $1.75, -0.57% vs the prior close of $1.76. Day range $1.71–$1.76, opened at $1.75.
- Volume was 560.70K shares, 0.9x its 50-day average of 649.66K.
- Price is -1.6% vs its 50-day average ($1.78) and -1.1% vs its 200-day average ($1.77).
- 52-week range $0.95–$3.62; today's close sits at 30% of that range, 51.6% below the 52-week high.
Oct 7, 2026 — HCAT dips 0.6% to $1.76
- Closed at $1.76, -0.56% vs the prior close of $1.77. Day range $1.72–$1.78, opened at $1.75.
- Volume was 240.70K shares, 0.4x its 50-day average of 650.82K — lighter than usual.
- Price is -1.5% vs its 50-day average ($1.79) and -0.7% vs its 200-day average ($1.77).
- 52-week range $0.95–$3.62; today's close sits at 30% of that range, 51.3% below the 52-week high.
Oct 6, 2026 — HCAT rises 0.6% to $1.77, 3 up days in a row
- Closed at $1.77, +0.57% vs the prior close of $1.76. Day range $1.75–$1.82, opened at $1.77.
- Volume was 225.20K shares, 0.3x its 50-day average of 653.70K — lighter than usual.
- Price is -1.4% vs its 50-day average ($1.80) and -0.3% vs its 200-day average ($1.78).
- 52-week range $0.95–$3.62; today's close sits at 31% of that range, 51.0% below the 52-week high.
- That makes 3 straight gains.
Oct 5, 2026 — HCAT rises 0.6% to $1.76
- Closed at $1.76, +0.57% vs the prior close of $1.75. Day range $1.73–$1.79, opened at $1.75.
- Volume was 230.20K shares, 0.4x its 50-day average of 657.57K — lighter than usual.
- Price is -2.4% vs its 50-day average ($1.80) and -1.0% vs its 200-day average ($1.78).
- 52-week range $0.95–$3.62; today's close sits at 30% of that range, 51.3% below the 52-week high.
Oct 2, 2026 — HCAT rises 2.9% to $1.75
- Closed at $1.75, +2.94% vs the prior close of $1.70. Day range $1.70–$1.76, opened at $1.71.
- Volume was 243.40K shares, 0.4x its 50-day average of 660.47K — lighter than usual.
- Price is -3.3% vs its 50-day average ($1.81) and -1.8% vs its 200-day average ($1.78).
- 52-week range $0.95–$3.62; today's close sits at 30% of that range, 51.6% below the 52-week high.
HCAT latest news & SEC filings
Every SEC filing by or about HCAT in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Oct 5, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Reller Tami received an award of 128,851 shares on Oct 1, 2026; now holds 128,851
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Oct 5, 2026 · Form 3 — New insider holdings
Initial insider ownership statement (Form 3) — a new director, officer or 10% owner disclosed their holdings
Sep 16, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Kohl Simeon received an award of 2,747,385 shares on Sep 14, 2026; now holds 2,797,385
- Kohl Simeon bought 59,000 shares at $1.79 (≈$105.44K) on Sep 14, 2026; now holds 2,856,385
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Sep 16, 2026 · Form 3 — New insider holdings
Initial insider ownership statement (Form 3) — a new director, officer or 10% owner disclosed their holdings
Sep 14, 2026 · Form S-8 — Employee share plan registration
Registration of shares for employee stock plans (S-8)
Sep 14, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 5.02 — Change in directors or officers (appointment, departure or pay).
- Item 7.01 — Released information under Regulation FD (e.g. a presentation or press release).
Sep 11, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Sep 10, 2026 · Form 144 — Planned insider sale
Notice of proposed sale (Form 144) — an insider or affiliate plans to sell restricted or control shares
A notice of intent, not a completed sale. Any actual sale by a director or officer shows up later on Form 4.
Sep 8, 2026 · Form SCHEDULE 13D/A — Update to a 13D 5%+ stake disclosure
Update to a 13D 5%+ stake disclosure
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Sep 8, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 5.02 — Change in directors or officers (appointment, departure or pay).
- Item 7.01 — Released information under Regulation FD (e.g. a presentation or press release).
Aug 14, 2026 · Form SCHEDULE 13G/A — Update to a passive 5%+ stake (13G)
Update to a passive 5%+ stake (13G)
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Aug 6, 2026 · Form 10-Q — Quarterly report
Quarterly report (unaudited financial statements for the quarter)
Quarter ended Jun 30, 2026:
- Revenue: $70.49M (prior year $80.72M) (-12.7% vs Jun 30, 2025)
- Net income: -$40.54M (prior year -$40.98M) (loss narrowed vs Jun 30, 2025)
- Diluted EPS: -$0.55 (prior year -$0.59) (loss narrowed vs Jun 30, 2025)
Aug 6, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 1.02 — Ended a material agreement.
- Item 2.01 — Completed an acquisition or sale of assets.
- Item 2.02 — Reported results of operations (earnings release).
- Item 7.01 — Released information under Regulation FD (e.g. a presentation or press release).
This is a results-day filing: the earnings press release is attached as an exhibit.
Jul 28, 2026 · Form SCHEDULE 13G/A — Update to a passive 5%+ stake (13G)
Update to a passive 5%+ stake (13G)
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Jul 21, 2026 · Form SCHEDULE 13G — Passive stake (13G)
Passive stake (13G) — an investor reported owning more than 5%
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Things to know before you trade HCAT
- Last results release: Aug 6, 2026 (8-K Item 2.02). Previous ones: May 11, 2026, Mar 12, 2026, Jan 12, 2026. Based on that rhythm, the next report is likely around Nov 5, 2026 — an estimate, not a confirmed date.
- How much it moves: over the last 20 sessions the average daily move was 1.85% (largest 9.0%).
- Liquidity: about 420.77K shares (≈$725.83K) trade per day on average. Thin volume can mean wider bid/ask spreads.
- 52-week position: $1.73 vs a range of $0.95–$3.62 (29% of the range).
- Dividends: no cash dividends in the last 2 years.
- Splits: none in the last 2 years.
- Insider trades (Form 4, last 12 months, recent 25 shown): 4 open-market buys, 8 sales; latest: Simeon Kohl bought 59,000 shares on Sep 14, 2026.
- Latest filings: 8-K Sep 14, 2026; 8-K Sep 8, 2026; 10-Q Aug 6, 2026.
- Share count: 75.26M shares outstanding (Jul 31, 2026), +6.9% vs a year earlier — notable dilution.
- Listing: Nasdaq · industry: Services-Computer Programming, Data Processing, Etc..
HCAT market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 16, 2026 | 1.80 | 1.84 | 1.72 | 1.73 | 176.67K |
| Oct 15, 2026 | 1.74 | 1.81 | 1.74 | 1.80 | 306.80K |
| Oct 14, 2026 | 1.71 | 1.75 | 1.71 | 1.74 | 458.30K |
| Oct 13, 2026 | 1.75 | 1.79 | 1.65 | 1.74 | 1.27M |
| Oct 12, 2026 | 1.79 | 1.81 | 1.71 | 1.75 | 345.30K |
| Oct 9, 2026 | 1.76 | 1.79 | 1.70 | 1.77 | 1.02M |
| Oct 8, 2026 | 1.75 | 1.76 | 1.71 | 1.75 | 560.70K |
| Oct 7, 2026 | 1.75 | 1.78 | 1.72 | 1.76 | 240.70K |
| Oct 6, 2026 | 1.77 | 1.82 | 1.75 | 1.77 | 225.20K |
| Oct 5, 2026 | 1.75 | 1.79 | 1.73 | 1.76 | 230.20K |
| Oct 2, 2026 | 1.71 | 1.76 | 1.70 | 1.75 | 243.40K |
| Oct 1, 2026 | 1.73 | 1.77 | 1.70 | 1.70 | 349.00K |
| Sep 30, 2026 | 1.76 | 1.79 | 1.72 | 1.73 | 383.60K |
| Sep 29, 2026 | 1.74 | 1.76 | 1.70 | 1.75 | 393.30K |
| Sep 28, 2026 | 1.72 | 1.77 | 1.71 | 1.77 | 532.60K |
| Sep 25, 2026 | 1.73 | 1.76 | 1.73 | 1.74 | 116.70K |
| Sep 24, 2026 | 1.73 | 1.76 | 1.71 | 1.74 | 706.90K |
| Sep 23, 2026 | 1.87 | 1.87 | 1.72 | 1.72 | 198.00K |
| Sep 22, 2026 | 1.81 | 1.89 | 1.76 | 1.89 | 341.20K |
| Sep 21, 2026 | 1.79 | 1.81 | 1.76 | 1.81 | 315.40K |
About Health Catalyst
Health Catalyst (HCAT) is listed on the Nasdaq and classified by the SEC under “Services-Computer Programming, Data Processing, Etc.”. Its business address is in SOUTH JORDAN, UT. State of incorporation: DE. Fiscal year ends December 31. SEC CIK 1636422.
HCAT board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| Benjamin Albert | CEO | Sep 11, 2026 |
| Mathew Paul Arens | Director | Dec 3, 2025 |
| Daniel D. Burton | Chief Executive Officer | Dec 3, 2025 |
| Duncan Gallagher | Director | Feb 19, 2026 |
| Green Jill Hoggard | Director | Jul 20, 2026 |
| Simeon Kohl | Chief Executive Officer | Sep 16, 2026 |
| Julie Larson-Green | Director | Sep 3, 2026 |
| Steven H Nelson | Director | Jul 20, 2026 |
| Justin Spencer | Director | Jul 20, 2026 |
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| Benjamin Albert | CEO | Sep 11, 2026 |
| Jason Alger | Chief Financial Officer | Sep 3, 2026 |
| Daniel D. Burton | Chief Executive Officer | Dec 3, 2025 |
| Kevin Lee Freeman | Chief Commercial Officer | Dec 3, 2025 |
| Simeon Kohl | Chief Executive Officer | Sep 16, 2026 |
| Benjamin Landry | General Counsel | Sep 3, 2026 |
| Linda Llewelyn | Chief People Officer | Jun 3, 2026 |
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| Sep 14, 2026 | Simeon Kohl | Buy | 59,000 | $1.79 |
| Sep 14, 2026 | Simeon Kohl | Buy | 59,000 | $1.79 |
| Sep 14, 2026 | Simeon Kohl | Buy | 59,000 | $1.79 |
| Sep 14, 2026 | Simeon Kohl | Buy | 59,000 | $1.79 |
| Dec 5, 2025 | Benjamin Landry | Sale | 27,425 | $2.64 |
| Dec 5, 2025 | Benjamin Landry | Sale | 27,425 | $2.64 |
| Dec 5, 2025 | Benjamin Landry | Sale | 27,425 | $2.64 |
| Dec 5, 2025 | Benjamin Landry | Sale | 27,425 | $2.64 |
| Dec 4, 2025 | Julie Larson-Green | Sale | 47,997 | $2.67 |
| Dec 4, 2025 | Julie Larson-Green | Sale | 47,997 | $2.67 |
| Dec 4, 2025 | Julie Larson-Green | Sale | 47,997 | $2.67 |
| Dec 4, 2025 | Julie Larson-Green | Sale | 47,997 | $2.67 |
HCAT financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| Dec 31, 2025 | $311.14M | $-177.97M | -2.55 | $731.00K |
| Dec 31, 2024 | $306.58M | $-69.50M | -1.15 | $14.56M |
| Dec 31, 2023 | $295.94M | $-118.15M | -2.09 | $-33.08M |
| Dec 31, 2022 | $276.24M | $-137.40M | -2.63 | $-35.27M |
| Dec 31, 2021 | $241.93M | $-153.21M | -3.23 | $-23.12M |
Latest balance sheet: total assets $358.60M, total liabilities $257.78M, cash $60.59M (as of Jun 30, 2026).
HCAT earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| Aug 6, 2026 | 8-K Item 2.02 (results) | $2.31 |
| May 11, 2026 | 8-K Item 2.02 (results) | $1.38 |
| Mar 12, 2026 | 8-K Item 2.02 (results) | $1.79 |
| Jan 12, 2026 | 8-K Item 2.02 (results) | $2.46 |
| Nov 10, 2025 | 8-K Item 2.02 (results) | $2.85 |
| Aug 7, 2025 | 8-K Item 2.02 (results) | $3.69 |
| May 7, 2025 | 8-K Item 2.02 (results) | $3.97 |
| Feb 26, 2025 | 8-K Item 2.02 (results) | $4.94 |
| Nov 6, 2024 | 8-K Item 2.02 (results) | $8.25 |
| Aug 7, 2024 | 8-K Item 2.02 (results) | — |
| May 9, 2024 | 8-K Item 2.02 (results) | — |
| Feb 22, 2024 | 8-K Item 2.02 (results) | — |
Related stocks · Services-Computer Programming, Data Processing, Etc.
Meta Platforms (META)Space Exploration Technologies (SPCX)Alphabet (GOOG)Nebius (NBIS)AppLovin (APP)Tempus AI (TEM)DigitalOcean (DOCN)Zoom Communications (ZM)Pinterest (PINS)Trade Desk (TTD)
Popular today
Spdr S&P 500 Etf (SPY)Micron Technology (MU)Nvidia (NVDA)Meta Platforms (META)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Tesla (TSLA)Apple (AAPL)Intel (INTC)Microsoft (MSFT)Amazon (AMZN)
More on HCAT
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 16, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.